The Center for Cancer Research (CCR) is the scientific engine driving basic and translational research at the Mass General Cancer Center.
Our vision is to contribute toward the eradication of cancer and lessen its burden across all communities, through scientific innovation and the rapid application of new discoveries.
Our mission is to conduct fundamental basic and translational research on cancer, through a highly innovative, multi-disciplinary and collaborative environment. We are committed to teaching and training the next generation of cancer researchers, within a diverse and inclusive research community. Through scientific innovation, we strive for global impact on the treatment, early diagnosis and prevention of all forms of cancer.
The principal goals of the CCR’s basic science faculty include:
- Identifying and characterizing novel genes and cellular processes involved in tumor cell growth, survival, and metastasis.
- Exploring how changes in genes and gene regulation affect the critical pathways that are altered in tumor cells.
- Learning to manipulate those pathways to combat cancer.
Engine For Discovery
The CCR is the engine for discovery for the Mass General Cancer Center, consistently ranked by U.S. News & World Report as one of the top cancer centers in the country. Working together, the CCR science faculty and Mass General Cancer Center's renowned clinical staff are recognized worldwide as pioneers in the new field of “personalized medicine.” Personalized medicine is based on the realization that every human tumor has unique characteristics, and that understanding those characteristics can provide vital information about disease progression and help predict the success or failure of today’s therapies. Researchers in the CCR are also deeply involved in the creation and development of “smart drugs” that target specific disease pathways to produce new, more effective anti-cancer drugs, potentially with fewer side effects.
The CCR has a dedicated faculty of over 40 independent investigators using state-of-the-art tools in a variety of fields: genetics, genomics, developmental biology, transgenic science, cancer immunology, advanced microscopy, computational biology, protein chemistry, engineering, pharmacology, and other fields. Recruited through competitive searches from leading universities and medical schools worldwide, the CCR’s principal investigators have faculty appointments in multiple clinical and basic science departments at Harvard Medical School. Together with their trainees and students, the CCR faculty occupies a total of 60,000 square feet of laboratory space in three research facilities at Mass General Hospital (Charlestown Navy Yard, the Jackson Building, and the Simches Research Building).
The unique strength of the CCR is the manner in which the CCR’s basic scientists collaborate with Mass General Cancer Center's leading oncologists and other physicians and medical professionals to meet the complex challenges presented by human cancer. At Mass General—one of the world’s most distinguished academic medical centers—the transfer of knowledge from basic research to clinical practice can happen in a matter of months, rather than the years required in many other settings.
See examples of key scientific discoveries made by CCR investigators that have substantially changed the way physicians understand and treat cancer.
As the engine for discovery, the CCR plays a vital role in the success of the Mass General Cancer Center. The CCR’s diverse studies using cell culture, fruit flies, mouse models, human tumor samples, computational modeling, and advanced microfluidic and robotic systems bring new promises of effective therapies and prevention for all types of human cancer.
Center for Cancer Research
The Center for Cancer Research serves as the engine for discovery for the Mass General Cancer Center. We have more than 40 independent laboratories with faculty drawn from all departments of Harvard Medical School. Our faculty study everything from cancer cell genetics and epigenetics, metabolism and microenvironments, cell signaling and DNA damage, with studies of cultured cells, all the way to patient derived samples and specimens.